Market closedNon-fractional
Emergent BioSolutions/EBS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Emergent BioSolutions
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
Ticker
EBS
Sector
Healthcare
Trading on
NYSE
Industry
Biotechnology
Headquarters
Gaithersburg, United States
Employees
1,600
Website
www.emergentbiosolutions.com
EBS Metrics
BasicAdvanced
$395M
Market cap
-
P/E ratio
-$10.93
EPS
1.64
Beta
-
Dividend rate
Price and volume
Market cap
$395M
Beta
1.64
Financial strength
Current ratio
1.083
Quick ratio
0.495
Long term debt to equity
67.284
Total debt to equity
136.451
Interest coverage (TTM)
-0.08%
Management effectiveness
Return on assets (TTM)
-0.38%
Return on equity (TTM)
-60.57%
Valuation
Price to revenue (TTM)
0.329
Price to book
0.6
Price to tangible book (TTM)
3.51
Price to free cash flow (TTM)
-2.815
Growth
Revenue change (TTM)
21.67%
Earnings per share change (TTM)
38.65%
3-year revenue growth
-11.43%
3-year earnings per share growth
15.39%
What the Analysts think about EBS
Analyst Ratings
Majority rating from 2 analysts.
EBS Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$300M
8.60%
Net income
$9M
-118.18%
Profit margin
2.99%
-116.71%
EBS Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$1.06
-$0.48
-$0.77
$0.59
-
Expected
-$0.49
-$0.22
-$0.19
-$0.86
-$0.95
Surprise
117.81%
114.93%
305.26%
-168.60%
-
EBS News
AllArticlesVideos
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
GlobeNewsWire·2 months ago
Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Emergent BioSolutions Reports First Quarter 2024 Financial Results
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Emergent BioSolutions stock?
Emergent BioSolutions (EBS) has a market cap of $395M as of July 06, 2024.
What is the P/E ratio for Emergent BioSolutions stock?
The price to earnings (P/E) ratio for Emergent BioSolutions (EBS) stock is 0 as of July 06, 2024.
Does Emergent BioSolutions stock pay dividends?
No, Emergent BioSolutions (EBS) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Emergent BioSolutions dividend payment date?
Emergent BioSolutions (EBS) stock does not pay dividends to its shareholders.
What is the beta indicator for Emergent BioSolutions?
Emergent BioSolutions (EBS) has a beta rating of 1.64. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Emergent BioSolutions stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.